AU2293892A - Enzyme-sensitive enteric preparation for oral administration - Google Patents

Enzyme-sensitive enteric preparation for oral administration

Info

Publication number
AU2293892A
AU2293892A AU22938/92A AU2293892A AU2293892A AU 2293892 A AU2293892 A AU 2293892A AU 22938/92 A AU22938/92 A AU 22938/92A AU 2293892 A AU2293892 A AU 2293892A AU 2293892 A AU2293892 A AU 2293892A
Authority
AU
Australia
Prior art keywords
enzyme
oral administration
enteric preparation
sensitive enteric
sensitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22938/92A
Inventor
Mayumi Narita
Toshiaki Nishihata
Ken Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of AU2293892A publication Critical patent/AU2293892A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
AU22938/92A 1991-07-01 1992-06-26 Enzyme-sensitive enteric preparation for oral administration Abandoned AU2293892A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3-160437 1991-07-01
JP16043791A JPH0525037A (en) 1991-07-01 1991-07-01 Oral administrative enzyme sensitive enteric coating

Publications (1)

Publication Number Publication Date
AU2293892A true AU2293892A (en) 1993-02-11

Family

ID=15714919

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22938/92A Abandoned AU2293892A (en) 1991-07-01 1992-06-26 Enzyme-sensitive enteric preparation for oral administration

Country Status (3)

Country Link
JP (1) JPH0525037A (en)
AU (1) AU2293892A (en)
WO (1) WO1993000891A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376688A (en) * 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
DE4322826A1 (en) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmaceutical preparation
JP4614258B2 (en) * 2001-06-12 2011-01-19 森下仁丹株式会社 Soft capsule with improved disintegration
US8231896B2 (en) 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
JP4718414B2 (en) * 2006-10-26 2011-07-06 アスモ株式会社 Embedded magnet type motor
NZ580209A (en) 2007-03-30 2011-11-25 Tmrc Co Ltd Tamibarotene capsule preparation
JP2013199458A (en) * 2012-03-26 2013-10-03 Tmrc Co Ltd Capsule preparation
WO2015045037A1 (en) * 2013-09-25 2015-04-02 テムリック株式会社 Capsule preparation
US10716761B2 (en) 2017-07-24 2020-07-21 Alcresta Therapeutics, Inc. Ingestible medical delivery devices
US20240156844A1 (en) * 2022-11-10 2024-05-16 Allen Greenspoon Orally administrable formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
DE2439538C3 (en) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Process for the manufacture of orally administered drugs with delayed release of action
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
DK160876C (en) * 1987-12-08 1991-10-14 Novo Nordisk As IMIDAZOQUINOXAL COMPOUNDS, PROCEDURES FOR THEIR PREPARATION, APPLICATION OF THE COMPOUNDS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE COMPOUNDS

Also Published As

Publication number Publication date
JPH0525037A (en) 1993-02-02
WO1993000891A1 (en) 1993-01-21

Similar Documents

Publication Publication Date Title
GB2257359B (en) Cyclosporin compositions for oral administration
AU8019991A (en) Programmed release oral solid pharmaceutical dosage form
PL314731A1 (en) S(+)-ibuprofen preparations for oral administration
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
GB9109862D0 (en) Pharmaceutical formulations
EP0873749A4 (en) Jellied medicinal composition for oral administration
AU1855392A (en) Dental floss
PL322579A1 (en) 2-methyl-thiene-benzodiazeoin prparation for oral administration
GB9117361D0 (en) Oral dosage form
AU5157590A (en) Pharmaceutical compositions for oral administration
PL314732A1 (en) S(+)-ethodolac preparations for oral administration
IL104236A0 (en) Oral anti-halitosis preparations
AU2429692A (en) Oral preparation for release in lower digestive tracts
HUT71131A (en) Paramycin formulations for oral administration
AU2027288A (en) Erythromycin formulations for oral administration
AU2293892A (en) Enzyme-sensitive enteric preparation for oral administration
PL307469A1 (en) Preparation for oral administration
ZA921093B (en) Pharmaceutical formulations
EP0953359A4 (en) Pharmaceutical composition for oral administration
AU5347996A (en) Preparation for oral administration
AU2493792A (en) Pharmaceutical preparation
AU9138891A (en) Nicotine-containing dental floss
AU4939690A (en) Anesthetic oral compositions
AU3162193A (en) Dental implant
EG19689A (en) New pharmaceutical preparation for oral use